Promising Pathway Act 2.0

[AI summary unavailable — showing source text] [Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [H.R. 9938 Introduced in House (IH)] <DOC> 118th CONGRESS 2d Session H. R. 9938 To amend the Federal Food, Drug, and Cosmetic Act to establish a time- limited conditional approval pathway, subject to specific obligations, for certain drugs and biological products, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES October 4, 2024 Mr. Westerman (for himself and Mr. Mike Garcia of California) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act to establish a time- limited conditional approval pathway, subject to specific obligations, for certain drugs and biological products, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Promising Pathway Act 2.0''. SEC. 2. CONDITIONAL APPROVAL OF NEW HUMAN DRUGS FOR INDIVIDUALS WIT…